MORINGA OLEIFERA LEAVES HAVE ANTI-DIABETIC ACTIVITY

Moringa oleifera leaves have significant anti-diabetic activity in a rat model. - GreenMedInfo Summary

http://www.greenmedinfo.com/article/moringa-oleifera-leaves-have-significant-anti-diabetic-activity-rat-model

Effect of Moringa oleifera Lam. leaves aqueous extract therapy on hyperglycemic rats

Abstract:

ETHNOPHARMACOLOGICAL RELEVANCE: 

In Indian traditional system of medicine, Moringa oleifera Lam. Syn. Moringa pterygosperma Gaerth (Moringaceae) is commonly used as healing herb to treat diabetes. 

AIM OF THE STUDY: 

The purpose of the present study was to assess the effect of M. oleifera leaves aqueous extract therapy on glycemic control, haemoglobin, total protein, urine sugar, urine protein and body weight. 

MATERIALS AND METHODS:

 Variable doses of 100, 200 and 300 mg kg(-1) of aqueous extract were administered orally by gavage for evaluating their hypoglycemic and antidiabetic effects on fasting blood glucose (FBG), oral glucose tolerance test (OGTT) and post prandial glucose (PPG) of normal and streptozotocin (STZ) induced sub, mild and severely diabetic rats.

 RESULTS: 

The dose of 200 mg kg(-1) decreases blood glucose level (BGL) of normal animals by 26.7 and 29.9% during FBG and OGTT studies respectively. In sub and mild diabetic animals the same dose produced a maximum fall of 31.1 and 32.8% respectively, during OGTT. In case of severely diabetic animals FBG and PPG levels were reduced by 69.2 and 51.2% whereas, total protein, body weight and haemoglobin were increased by 11.3, 10.5 and 10.9% respectively after 21 days of treatment. Significant reduction was found in urine sugar and urine protein levels from +4 and +2 to nil and trace, respectively. 

CONCLUSION: 

The study validates scientifically

 the widely claimed use of 

M. oleifera as an 

ethnomedicine to 

treat diabetes mellitus.

Academic Cite:

Dolly Jaiswal, Prashant Kumar Rai, Amit Kumar, Shikha Mehta, Geeta Watal. 

Effect of Moringa oleifera Lam. leaves aqueous extract therapy on hyperglycemic rats. 

J Ethnopharmacol. 2009 Jun 25;123(3):392-6. Epub 2009 Apr 5.

Pubmed-Cite:
IMPT NOTE:

MORINGO NUTRA CAPSULES ARE NOT DRUG AND MEDICINES TO ANY DISEASES.

NO HEALTH CLAIM SHOULD ENTERTAINED.

FDA APPROVED MORINGO ORGANICS  AS FOOD SUPPLEMENTS ONLY AND NOT AS MEDICINE.

THE MESSAGES IN THIS BLOG HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. AND MORINGO ORGANICS COMPANY.

THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE

ANTI-DIABETIC ACTIVITY OF MORINGO OLEIFERA

Evaluation of antidiabetic and antioxidant activity of Moringa oleifera in experimental diabetes

Oleifera, the widely cultivated species in 

India is an exceptionally nutritious 

vegetable with a variety of potential uses 

in treating rheumatism, venomous bites

 and microbial infections. The antidiabetic

 and antioxidant effect of methanol extracts

 of Moringa oleifera pods in streptozotocin 

(STZ)-induced diabetes in rats was studied

. Methanolic extract of M. oleifera (MOMtE)

 was studied for antidiabetic effect on 

STZ-induced diabetes on albino rats. 

The protection was measured by changes

 in biochemical parameters of serum and 

pancreas tissue. Diabetic rats were treated

 daily with different doses of MOMtE, 

i.e. 15 and 3 mg/kg b. wt./day for 21 days. 

Two phytoconstituents, quercetin and 

kaempfero

l were isolated from the MOMtE extract 

and structures were determined using 

NMR and IR spectroscopy. The data of

 present study demonstrated that the progression of diabetes significantly reduced after M

OMtE treatment. MOMtE induced a

 significant reduction in serum glucose

 and nitric oxide with

 concomitant increase in serum insulin

 and protein levels. Furthermore, MOMtE

 treatment increased the pancreas

 tissue antioxidant level with concomitant

 decrease in the level of thiobarbituric 

acid-reactive oxygen species. The histologic

 examination of pancreas of diabetic 

rats showed degenerative changes in the 

number of β-cells, while MOMtE treatment

 significantly regenerated the islets cells. 

Moringa oleifera exerts protective effect 

against STZ-induced diabetes. From present study it can be concluded that methanolic e

xtract of M. oleifera possess significant

 antidiabetic and antioxidant activity and may be considered in isolation of active cons

tituents for clinical studies.

http://scienceindex.com/stories/1972728/Evaluation_of_antidiabetic_and_antioxidant_activity_of_Moringa_oleifera_in_experimental_diabetes.htm

MORINGO NUTRA CAPSULES ARE NOT DRUG AND MEDICINES TO ANY DISEASES.

NO HEALTH CLAIM SHOULD ENTERTAINED.

FDA APPROVED MORINGO ORGANICS  AS FOOD SUPPLEMENTS ONLY AND NOT AS MEDICINE.

THE MESSAGES IN THIS BLOG HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. AND MORINGO ORGANICS COMPANY.

THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE

EVALUATION OF ANTI-DIABETIC and ANTIOXIDENT ACTIVITY OF MORINGO OLEIFERA

Evaluation of antidiabetic and antioxidant activity of Moringa oleifera in experimental diabetes.

http://www.ncbi.nlm.nih.gov/pubmed/22103446

Abstract

BACKGROUND:

Moringa oleifera, a widely cultivated species in India, is an exceptionally nutritious vegetable with a variety of potential uses in treating rheumatism, venomous bites, and microbial infections. In the present study, we investigated the antidiabetic and antioxidant effects of methanol extracts of M. oleifera pods (MOMtE) in streptozotocin (STZ)-induced diabetic albino rats.

METHODS:

Diabetic rats were treated with 150 or 300 mg/kg MOMtE for 21 days and the antidiabetic effects of the extract were evaluated by measuring changes in biochemical parameters in the serum and pancreatic tissue. Two phytoconstituents, namely quercetin and kaempferol, were isolated from the MOMtE extract and their structures were determined using nuclear magnetic resonance and infrared spectroscopy.

RESULTS:

The progression of diabetes was significantly reduced after MOMtE treatment. In treated rats, both doses of MOMtE induced a significant reduction in serum glucose and nitric oxide, with concomitant increases in serum insulin and protein levels. Furthermore, MOMtE treatment increased antioxidant levels in pancreatic tissue, with concomitant decreases in levels of thiobarbituric acid-reactive substances. Histologic examination of the pancreas from diabetic rats showed degenerative changes in β-cells; MOMtE treatment significantly reversed the histoarchitectural damage to the islets cells.

CONCLUSION:

In conclusion, M. oleifera exerts protective effects against STZ-induced diabetes. The MOMtE exhibited significant antidiabetic and antioxidant activity and active constituents may be isolated from the extract for evaluation in future clinical studies.

© 2011 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and Blackwell Publishing Asia Pty Ltd.

from http://www.ncbi.nlm.nih.gov/pubmed/22103446
+++++++++++++++++++++++++++++++++++++++

MORINGO NUTRA CAPSULES ARE NOT DRUG AND MEDICINES TO ANY DISEASES.

NO HEALTH CLAIM SHOULD ENTERTAINED.

FDA APPROVED MORINGO ORGANICS  AS FOOD SUPPLEMENTS ONLY AND NOT AS MEDICINE.

THE MESSAGES IN THIS BLOG HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. AND MORINGO ORGANICS COMPANY.

THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE

NATURAL SUPPLEMENT FOR DIABETES- MORINGO OLEIFERA

Natural Suplement for Diabetes – Moringa Oleifera

+

MORINGO NUTRA CAPSULES ARE NOT DRUG AND MEDICINES TO ANY DISEASES.

NO HEALTH CLAIM SHOULD ENTERTAINED.

FDA APPROVED MORINGO ORGANICS  AS FOOD SUPPLEMENTS ONLY AND NOT AS MEDICINE.

THE MESSAGES IN THIS BLOG HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. AND MORINGO ORGANICS COMPANY.

THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE

MORINGO OLEIFERA FOR DIABETES

Moringa Oleifera for Diabetes

+

MORINGO NUTRA CAPSULES ARE NOT DRUG AND MEDICINES TO ANY DISEASES.

NO HEALTH CLAIM SHOULD ENTERTAINED.

FDA APPROVED MORINGO ORGANICS  AS FOOD SUPPLEMENTS ONLY AND NOT AS MEDICINE.

THE MESSAGES IN THIS BLOG HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. AND MORINGO ORGANICS COMPANY.

THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE

ANTIDIABETIC EFFICACY OF MORINGA OLEIFERA

<MORINGO AND DIABETES>

ANTIDIABETIC EFFICACY OF MORINGA OLEIFERA LEAVES IN STREPTOZOTOCIN INDUCED DIABETIC

The methanol extract of leaves of Moringa oleifera was evaluated for its antidiabetic efficacy in streptozotocin induced diabetic rats. Diabetes was induced by a single intraperitoneal injection of streptozotocin ( 45 mg/kg body weight). Methanol extract administered orally at dose of 300 mg/kg body weight for 35 days in diabetic rats. Blood glucose level, liver glycogen, muscle glycogen, insulin as well as initial and final changes in body weight were evaluated. Experimental studies showed significant antidiabetic efficacy of extract in case of reduction of blood glucose level in diabetic rats. Significant improvement was observed in liver and muscle glycogen , insulin level and body weight profiles in methanol extract –treated diabetic rats . The effect of the extract at 300 mg/kg body weight was comparable to that of standard drug glibenclamide ( 5 mg/kg body weight). Key words : Streptozotocin, antidiabetic, Moringa oleifera, glibenclamide

Introduction Diabetes is a complex multisystemic disorder characterized by a relative or absolute insufficiency of insulin secretion and disturbances in carbohydrate, protein, lipid metabolism. [1,2] It is an insidious disease. Although the prevalenceof diabetes is increasing, diabetes is not homogenously distributed throughout the population.[3] “Diabetes” means siphon and “mellitus” stands for sweet. Chronic hyperglycemia during diabetes causes gyration of body proteins that in turn leads to secondary complications affecting eyes (retinopathy),kidneys (nephropathy), nerves (neuropathy) and arteries (atherosclerotic vascular disease).The International Diabetes Federation has predicted that the number of indivisuals with diabetes will increase from 240 million in 2007 to 380 million in 2025 with 80% of the disease burden in low and middle-income countries.[4] It also estimated that the number of diabetic patients in India more than doubled from 19 million in 1995 to 40.9 million in 2007 and is projected to increase to 69.9 million by 2025. So India is the diabetes capital of the world. According to recent estimation, the global population is approaching the midst of diabetes pandemic. Although various oral hypoglycemic drugs exist alongside insulin, still there is no promising therapy to cure diabetes. On the other hand from time immemorial, man depended on plants as medicine. From historical perspective, it is evident that the fascination for plants is as old as mankind itself. The plant kingdom represents a rich storehouse of organic compounds, many of which have been used for medicinal purposes and could serve as lead for the development of novel agents having good efficacy in various pathological disorders in the coming years.[5] Many of traditional medicinal plants have been used successfully since ancient times to treat diabetes and related complications because plants have been the major source of drugs for the treatment of diabetes mellitus in Indian system of medicine and other ancient systems in the world, though their biologically active compounds are unknown. [6] Ethnobotanical information indicates that more than 800 plants are used as traditional remedies for the treatment of diabetes due to their effectiveness, less side effects and relatively low cost. [7] Botanical products can improve glucose metabolism and the overall condition of individuals with diabetes not only by hypoglycemic effects but also by improving lipid metabolism, antioxidant status and capillary function. [8] Recently numerous traditional medicinal plants were tested for their antidiabetic potential in the experimental animals. In the present investigation is directed to the exploration of antidiabetic efficacy of the methanol extract of leaves of Moringa oleifera . Moringa oleifera is the most widely cultivated species of a monogeneric family, the moringaceae and the most nutrient rich plant on the earth. Three non-governmental organizations in particular- Trees for Life, Church World Service and Educational Concerns for hunger Orgnization- have advocated Moringa as “natural nutrition for the tropics. [9] Moringa oleifera is mentioned in the “Shushruta Sanhita” which was written in the beginning of the first century A.D. there is evidence that the cultivation of this tree in India dates back many thousands of years and all over world due to high protein, vitamins, carbohydrate content of entire plant ,high value of nutrition for both humans and live stock. [10,11] It is also called “Drumstick Tree” or “ Horse Radish Tree”.It is soft wood tree, short slender, deciduos, perennial tree with drooping branches, corky bark, leaves feathery pale green, compound, tripinnate. All parts are used in Ayurvedic system of medicine. [12] The plant was reported to contain various amino acids, fatty acids, vitamins and its constituents such as leaf, flower, fruit and bark have been anecdotally used as herbal medicine in the treatment for inflammation, paralysis and hypertension, psychosis, eye diseases, fever and as an aphrodisiac. It is highly potent anti-inflammatory, hepatoprotective, antihyperytensive and anti-tumor [13,14] which for centuries has been advocated for traditional and industrial uses. All parts of the Moringa tree are edible and have long been consumed by humans. It is mother’s best friend because it increases woman’s milk production. It is reported to elicit good clinical response in children suffering from upper respiratory tract infection .[15] Leaves can be eaten fresh,cooked, refrigeration, and reportedly without loss of nutritional value. [9] Leaves have been reported to be a rich source of beta carotene, protein, amino acid, vitamin C, calcium and potassium. [12] This makes Moringa leaves an ideal, safe and natural treatment with wide medicinal uses such as cleaning the body from toxins, strengthening the immune system, support to Gout and Arthritis supporting treatment and much more. Leaves contain- 7 types of vitamins, 6 types of minerals, 18 types of Amino Acids, 46 types of anti-oxidants. Leaves can help maintain normal blood sugar level. The leaves and fruits are found to have hypocholesterolaemic activity in Wistar rats and rabbits. [16]

MATERIALS AND METHODS Plant Material Leaves of Moringa oleifera were collected in the month of February 2009 from Bhabha Atomic Research Centre campus, Mumbai, Maharashtra, India. The plant was authenticated by Dr. Harshad Pandit, Head Dept. Botany, G.N. Khalsa College, Matunga, Mumbai, India. A voucher specimen no. is PZ/1503b.

Preparation of Methanol Extract Methanol extract of Moringa leaves was prepared by Soxhlet method with 50 gm powder + 300 ml methanol. Leaves of Moringa oleifera were shade dried, the leaf powder was prepared using home grinder no. IS: 4250CM/L-7480681 Orange Company. The extract was stored in desicator for use in subsequent experiment. Animals Healthy Wistar strain male albino rats weighing 240-280 gms and 10-12 weeks old were used for the study. Animals were procured from Haffkine’s Biopharmaceuticals Private Limited (HBPL), Parel, Mumbai. The animals were acclimatized to laboratory conditions for 7 days prior to experiment. They were housed in polypropylene cages at an ambient temperature of 25-30 °C with a 12 hour each of dark and light cycle in the animal room. The rats were fed with standard pellet diet ( Amrut Feed) and water ad libitum. The principles of Laboratory Animals’ Care were followed and instructions given by institutional animal ethical committee (525/02/a/CPCSEA) were followed throughout the experiment. Six rats were used for all studies in each group.

Chemicals Streptozotocin, a most widely used chemical diabetogen was purchased from SRL Chemicals, Mumbai, India. All reagents used in the experiment were of analytical grade. Glibenclamide a standard antidiabetic agent was procured from chemist, Mumbai.

Induction of diabetes with STZ Diabetes was induced in overnight fasted Wistar strain male albino rats weighing 240-280 gms by intraperitoneal injection of freshly prepared STZ in 0.1 M citrate buffer pH=4.5 [13] ( 45 mg/kg body weight). Fasting blood glucose level was estimated at the time of induction of diabetes and post prandinal glucose (PPG) was checked regularly each alternate day till 35 days and showed stable blood sugar level they were used for antidiabetic study.

Experimental Design Aniamls were divided into four groups of six rats each. They are i) Normal group ii) Test (Moringa lvs extract) group iii)Standard group (glibenclamide) iv) Diabetic control group. Normal group received only distilled water. Test group was administered methanol extract of Moringa oleifera leaves at dose of 300mg/kg body weight(once a day daily) by oral route. Standard group was treated with standard drug glibenclamide at an oral dose of 5 mg/kg body weight. Diabetic control group was treated with only vehicle 0.5% CMC solution at 1ml/kg once a day daily. [18] The blood sugar level(mg/dL) was estimated every alternate day. Liver and muscle glycogen determined by Amyloglucosibase. [ 19 ] and insulin was evaluated by Chemiluminescence method. Initial and final body weight was also recorded. [20]

RESULTS Acute Toxicity Studies The albino swiss mice were treated with Moringa oleifera for a period of 14 days for toxicity study. The toxicity studies revealed nontoxic nature of the Moringa oleifera at a concentration of 2 and 5gm/kg of body weight/day for a period of 14 days. There was no morphological changes like condition of fur, skin damage, subcutaneous swelling,eye dullness, pupil diameter, ptosis, condition of teeth, breathing distress, gait, weight loss, etc. There was no lethality or any toxic reactions found at either doses selected till the end of treatment period. Body Weight The changes in initial and final body weight are listed in Table 2. observed data indicates significant improvement of body weight profile ( P< 0.05 at 300 mg/kg body weight) in extract and glibenclamide – treated diabetic rats with respect to diabetic control group. Fig 1: Comparison of blood glucose of normal, diabetic, std drug treated and Moringa oleifera treated rats

Table 1: Effect of methanol extract of Moringa oleifera leaves on liver glycogen, Muscle glycogen , Insulin of STZ- induced diabetic rats

Group Liver Glycogen Muscle Glycogen Insulin Normal Control 51.94±0.88 9.6±0.31 16.46±0.17 Diabetic Control 18.45±0.33 1.86±0.12 5.33±0.21 Diabetic+ MOME 300 mg/kg 45.18±0.79 8. 43±0.33 14.0±0.28 Diabetic + Std Drug 5mg/kg 46.19±0.14 9.5±0.33 12.46±0.15

Table 2: Effect of methanol extract of leaves of Moringa oleifera on body weight profile of STZ-induced diabetic rats Group Initial Body weight ( Gram) Final Body weight (Gram) Normal control 236.66±25.23 285±5.47 Diabetic control 241.66±22.06 134.16±4.91 Daibetic+MOME 300 mg/kg 237.5±20.91 207.5±8.21 Daibetic +Std drug 5 mg/kg 235.83±19.08 235.00±18.7

Biochemical Parameters 1)Blood Glucose : Blood glucose levels in rats of different groups are shown in Fig 1. The effect of methanol extract of Moringa oleifera leaves on blood glucose level of STZ induced diabetic rats was observed. The glucose level was significantly high in diabetic control group. On the other hand , the level of blood glucose was significantly decreased in treated groups ( Moringa extract and Glibenclamide) compared with normal and control groups.

2)Glycogen: The liver glycogen, muscle glycogen of control and experimental groups of rats were evaluate after the termination of experiment i.e 35 th day and represented in Table 1 .The liver ,muscle glycogen significantly decreased in diabetic group , when compared to normal control group, and significantly increased after the treatment of Moringa oleifera and std. drug glibenclamide, compared to diabetic group. 3)Insulin: Insulin level of control and experimental groups of rats was estimated and presented in Table 1. The insulin level was significantly decreased in diabetic group when compared with normal group. Treatment with methanol extract of Moringa oleifera and standard drug glibenclamide significantly increased the level of insulin when compared with diabetic group.

DISCUSSION The STZ is a broad-spectrum antibiotic, glucosamine-nitrosourea compound extracted from Streptomyces acromogenes. [21] It is toxic to the insulin-producing beta cells of the pancreas in mammals. STZ induces sever and irreversible hyperglycemia in experimental animal. [22] So it is suggested the drug as an animal model of diabetes. Rats with STZ-induced diabetes have reduced body weight, hyperglycemia, and hypoinslinemia because of damaged insulin-secreting cells in pancreatic islets. [23] The body weight of STZ-induced diabetic male wistar rats were decreased and recovered after the treatment. In our study the body weight was increased in Moringa oleifera and glibenclamide treated diabetic rats. The toxicity studies revealed nontoxic nature of the Moringa oleifera. The treatment of anti-diabetic medicinal plant extract to the STZ-induced male albino wistar rats, that activated the ß cells return to normal. The glibenclamide is a standard antidiabetic drug, used to compare the antihyperglycemic property in experimental rats. Glibenclamide stimulate insulin secretion from pancreatic ß cells by inhibiting ATP-sensitive potassium channels in pancreatic ß cell membrane. [21] The blood glucose level increases in diabetic rat. [25] An extract from the Moringa leaf has been shown to effective in lowering blood sugar levels within 3 hrs. ingestion, though less effectively than the standard hypoglycemic drug, glibenclamide. [26] In our study glibenclamide and Moringa oleifera treated diabetic rats by STZ induction showed decrease in blood glucose level. Simultaneously it was observed increased plasma insulin level . Insulin was increased in Moringa oleifera treated and glibenclamide treated diabetic rats. The glycogen content is decreases in liver and muscle of diabetic rats [25] and recovered ( increased) significantly in Moringa oleifera treated diabetic rats and glibenclamide treated diabetic rats.

STATASTICAL ANALYSIS Data were stastically calculated by utilizing one-way ANOVA and expressed as ±S.E.M..The significance of the difference between the means of test and control studies was established by Dunnett’s t-test. P values less than 0.05 were considered significant. CONCLUSION The administration of Moringa oleifera is a significant restoration of the blood glucose, liver and muscle glycogen and insulin. The result of this investigation revealed that methanol extract of leaves of Moringa oleifera possesses significant antidiabetic activity in STZ-induced diabetic rats in dose dependent manner. The Moringa oleifera enhance the glycolytic enzymes and controls the glucose metabolism in the liver tissues of STZ- induced diabetic rats that leads to normoglycemic . The extract restore body weight also.

REFERENCES

1. Gandhipuram Periasamy, Sentil Kumar, Palanisamy Arulselvan, Durairaj Satish Kumar, Sorimuthu Pillai Subramanian.Antidiabetic Activity of fruits of Terminalia chebula on STZ induced diabetic rats. Journal of Health Science, 52(3) 283-91(2006). 2. Rakesh Barik, Sanjay Jain, Deep Qwatra, Amit Joshi, Girraj Sharan Tripathi, Ravi Goyal. Antidiabetic activity of aqueous root extract of Ichnocarpus frutescens in STZ-nicotinamide induced type II diabetes in rats. Indian J. Pharmacology, February 2008,vol.40, Issue 1, p. 19-22.

3. Michael J. Fowler.Diabetes: Magnitude and Mechanisms. Clinical Diabetes. Volume 28, Number 1, 2010. . 4. Juliana C.N. Chan, Vasanti Malik, Weiping Jia, Takashi Kadowaki, Chittaranjan S.Yajnik, Kun-Ho Yoon, Frank B. Hu. Diabetes in Asia Epidemology, Risk Factors, and Pathophysiology. American Medical Association. May 27, 2009- Vol 301, No. 20 . pp 2129-40. 5. Bhoomika R Goyal, Babita B Agrawal, Ramesh K Goyal and Anita A Mehta .Natural Product Radiance, Vol 6(4), 2007, pp 347-53. 6. S .B .Sharma, A. Nasir, K .M. Prabhu, P .S. Murthy, G. Dev. Hypoglycaemic and hypolipidemic effect of ethanolic extract of seeds of Eugenia jambolana in alloxan-induced diabetic rabbits. Journal of Ethanopharmacology 85(2003) 201-6. 7. Rathod Nanu, Raghuveer I, Chitme H.R., Ramesh Chandra. Antidiabetic Activity Of Nyctanthes Arbortristis. Pharmacognosy Magazine ,Vol 4, Issue 16, Oct- Dec, 2008). 8. Alam Khan, Mahpra Safdar, Mohmmad Muzaffar Ali Khan, Khan Nawaz Khattak, Richard A. Anderson. Cinnamon Improves Glucose and Lipid of People with Type 2 diabetes. Diabetes Care; 2003, 26(12):3215-18. 9. Jed W. Fahey. Trees for Life Journal 2005,1:5 ( downloaded fromhttp://wwwTFLJournal.org/article.php /20051201124931586). 10. Foidl N., Makkar H.P.S. and Becker K. What development potential for Moringa Product? October 20th November 2 nd 2001. Dar Es Salaam. 11. A.A. Adedapo, O.M. Mogbojuri and B.O. Emikpe . Safety evaluations of the Research. Vol.3 (8), pp. 586-91. 12. Vidya Sabale, Vandana Patel, Archana Paranjape, Chitra Arya, S.N. Sakarkar and P.M. Sabale.Plant Review. Moringa oleifera(Drumstick) : An Overview. Pharmacognosy Reviews- supplement vol 2, Issue 4, Jul-Dec, 2008, p 7-13) 13. Ping-Hsien Chuang, Chi-Wei Lee, Jia-Ying Chou, M. Murugan, Bor-Jinn Shieh, Hueih Minchen. Anti-fungal acitivity of crude extracts and essential oil of Moringa oleifera Lam. Bioresource Technology 98 (2007) 232-6. 14. A.K. Nadkarni: Indian Materia Medica. Vol I. 1st ed. Mumbai. Popular Prakashan. 72( 1973). 15. Anita Mehta and Babita Agrawal. Investigation into the mechanism of action of Moringa oleifera for its anti-asthmatic activity, Oriental Pharmacy and Experimental Medicine 2008, 8(1), 24-31. 16. Pilaipark Chumark, Panya khunawat, Yupin Sanvarinda, Srichan Phornchira silp, Noppawan phumala Morales, Laddawal Phivthong-ngam, Piyanee Ratanchamnong, Supath Srisawat, Klai-upsorn S. Pongrapeeporn . The in vitro and ex vivo antioxidant properties, hypolipidaemic and antiatherosclerotoc activites of water extract of Moringa oleifera Lam. Leaves. Journal of Ethnopharmacology 116(2008) 439-46. 17. Mahmoud Abu Abeeleh, Zuhair Bani Ismail, Khaled R. Alzaben, Sami A. Abu-Halaweh, Mohamed K. Al-Essa Jaafar Abuabeeleh, Moaath. M. Alsmady. European Journal of Scientific Research. Vol. 32 no. 3( 2009), pp. 398-402. 18. Nima Thakkar, Jagruti A Patel. Pharmacological evaluation of “Glyoherb”: A polyherbal formulation on STZ-induced diabetic rats. Int J Diab Dev Ctries 2010; 30:1-7. 19. Hans Ulrich Bergmeyer. Methods of Enzymatic Analysis. In collaboration with Karlfried Gawehn, 2 nd English Edition. Translated from the Third German edition (1974) pp 1127-31. 20. Saikat Dewanjee, Sekhar K. Bose, Ranbir Sahu, Subhash C. Mandal. Antidiabetic effect of matured fruits of Diospyros peregrine in alloxan-induced diabetic rats. International Journal of Green Pharmacy.April-June 2008 pp95-99. 21. Periyar Selvam Sellamuthu, Balu Periamallipatti Muniappan, Sathiya Moorthi Perumal, and Murugesan Kandasamy. Antihyperglycemic Effect of Mangiferin in Streptozotocin Induced Diabetic Rats. Journal of Health Science, 55(2) 206-214(2009). 22. Mitra,S.K., Gopumadhvan, S., Muralidhar, T.S. and Seshadri, S.J. Effectof D-400 a Herbomineral Formulation on Liver Glycogen Content and Microscopic Structure of Pancreas and Liver in Streptozotocin-induced Diabetes in Rats. Indian Journal of Experimental Journal(1996):(34), Oct., 964-7. 23. Jae-Jeong Lee, Ho-Youg Yi, Jae-Won Yang, Jun-Seop shin, Jai-Hyun Kwon and Chan Wha Kim. Characterization of STZ-induced Diabetic Rats and Pharma codynamics of Insulin Formulations. Biosci.Biotechnil.Biochem,67(11),2396-2401, 2003. 24. M.V. Mikhailov, E.A.Mikhailova and S.J.H.Ashcroft. Structure-function relationships in the ß-cell KATP Channel. Biochemical Society Transactions (2002) 30, (323-7). 25. Daisy Pitchai, Azhagu Saravana Babu, Rajathi Modilal. Antihyperglycemic Effect of Phyllanthus Extracts in Alloxan-Induced Diabetic Rats. Int.J. Ph. Sci/Sept-December 2009/Vol. 1/Issue2/261-4. 26. Aney J.S., Rashmi Tambe, Maushumi Kulkarni, Kiran Bhise. Journal Of Pharmacy Research 2009, 2(9), 1424-6.
++

MORINGO NUTRA CAPSULES ARE NOT DRUG AND MEDICINES TO ANY DISEASES.

NO HEALTH CLAIM SHOULD ENTERTAINED.

FDA APPROVED MORINGO ORGANICS  AS FOOD SUPPLEMENTS ONLY AND NOT AS MEDICINE.

THE MESSAGES IN THIS BLOG HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. AND MORINGO ORGANICS COMPANY.

THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE

REFERENCES

• Abdel-Halim S. M., Ostenson C. G., Andersson A., Jansson L., Efendic S. (1995). A defective stimulus-secretion coupling rather than glucotoxicity mediates the impaired insulin secretion in the mildly diabetic F1 hybrids of GK-Wistar rats. Diabetes 44, 1280–1284. doi: 10.2337/diabetes.44.11.1280. [PubMed] [Cross Ref]
• Abeles R. H., Frey P. A., Jencks W. P. (1992). “Complex lipids,” in Biochemistry (Boston: Jones and Bartlett Publishers; ), 739–761.
• Adedapo A. A., Mogbojuri O. M., Emikpe B. O. (2009). Safety evaluations of the aqueous extract of the leaves of Moringa oleifera in rats. J. Med. Plant 3, 586–591.
• Adult Treatment Panel III. (2001). Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285, 2486–2497. doi: 10.1001/jama.285.19.2486. [PubMed] [Cross Ref]
• Aje T. O., Miller M. (2009). Cardiovascular disease: a global problem extending into the developing world. World J. Cardiol. 1, 3–10. doi: 10.4330/wjc.v1.i1.3. [PMC free article] [PubMed][Cross Ref]
• Alberti K. G., Zimmet P. Z. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15, 539–553. doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S. [PubMed] [Cross Ref]
• Amaglo N. K., Bennett R. N., Lo Curto R. B., Rosa E. A. S., Lo Turco V., Giuffrid A., Lo Curto A., Crea F., Timpo G. M. (2010). Profiling selected phytochemicals and nutrients in different tissues of the multipurpose tree Moringa oleifera L., grown in Ghana. Food Chem. 122, 1047–1054. doi: 10.1016/j.foodchem.2010.03.073. [Cross Ref]
• Anwar F., Latif S., Ashraf M., Gilani A. H. (2007). Moringa oleifera: a food plant with multiple medicinal uses. Phytother. Res. 21, 17–25. [PubMed]
• Aslam M., Anwar F., Nadeem R., Rashid U., Kazi T. G., Nadeem M. (2005). Mineral composition of Moringa oleifera leaves and pods from dfferent regions of Punjab, Pakistan. Asian J. Plant Sci.4, 417–421. doi: 10.3923/ajps.2005.417.421. [Cross Ref]
• Atawodi S. E., Atawodi J. C., Idakwo G. A., Pfundstein B., Haubner R., Wurtele G., Bartsch H., Owen R. W. (2010). Evaluation of the polyphenol content and antioxidant properties of methanol extracts of the leaves, stem, and root barks of Moringa oleifera Lam. J. Med. Food 13, 710–716. doi: 10.1089/jmf.2009.0057. [PubMed] [Cross Ref]
• Bennett R. N., Mellon F. A., Foidl N., Pratt J. H., Dupont M. S., Perkins L., Kroon P. A. (2003).Profiling glucosinolates and phenolics in vegetative and reproductive tissues of the multi-purpose trees Moringa oleifera L. (horseradish tree) and Moringa stenopetala L. J. Agric. Food Chem. 51, 3546–3553. doi: 10.1021/jf0211480. [PubMed] [Cross Ref]
• Bisbis S., Bailbe D., Tormo M. A., Picarel-Blanchot F., Derouet M., Simon J., Portha B. (1993).Insulin resistance in the GK rat: decreased receptor number but normal kinase activity in liver.Am. J. Physiol. 265, E807–E813. [PubMed]
• Bischoff S. C. (2008). Quercetin: potentials in the prevention and therapy of disease. Curr. Opin. Clin. Nutr. Metab. Care 11, 733–740. doi: 10.1097/MCO.0b013e32831394b8. [PubMed][Cross Ref]
• Bortolotti M., Levorato M., Lugli A., Mazzero G. (2008). Effect of a balanced mixture of dietary fibers on gastric emptying, intestinal transit and body weight. Ann. Nutr. Metab. 52, 221–226. doi: 10.1159/000138127. [PubMed] [Cross Ref]
• Bour S., Visentin V., Prevot D., Daviaud D., Saulnier-Blache J. S., Guigne C., Valet P., Carpene C. (2005). Effects of oral administration of benzylamine on glucose tolerance and lipid metabolism in rats. J. Physiol. Biochem. 61, 371–379. doi: 10.1007/BF03167054. [PubMed] [Cross Ref]
• Buraimoh A. A. (2011). Hepatoprotective effect of ethanolic leave extract of Moringa oleifera on the histology of paracetamol induced liver damage in Wistar rats. Int. J. Anim. Vet. Adv. 3, 10–13.
• Cajuday L. A., Pocsidio G. L. (2010). Effects of Moringa oleifera Lam. (Moringaceae) on the reproduction of male mice (Mus musculus). J. Med. Plant Res. 4, 1115–1121.
• Chakravarti R. N. (1955). Chemical identity of moringine. Bull. Calcutta Sch. Trop. Med. 3, 162–163.
• Cheenpracha S., Park E. J., Yoshida W. Y., Barit C., Wall M., Pezzuto J. M., Chang L. C. (2010).Potential anti-inflammatory phenolic glycosides from the medicinal plant Moringa oleifera fruits.Bioorg. Med. Chem. 18, 6598–6602. doi: 10.1016/j.bmc.2010.03.057. [PubMed] [Cross Ref]
• Cho A. S., Jeon S. M., Kim M. J., Yeo J., Seo K. I., Choi M. S., Lee M. K. (2010). Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice.Food Chem. Toxicol. 48, 937–943. doi: 10.1016/j.fct.2010.01.003. [PubMed] [Cross Ref]
• Chumark P., Khunawat P., Sanvarinda Y., Phornchirasilp S., Morales N. P., Phivthong-Ngam L., Ratanachamnong P., Srisawat S., Pongrapeeporn K. U. (2008). The in vitro and ex vivo antioxidant properties, hypolipidaemic and antiatherosclerotic activities of water extract ofMoringa oleifera Lam. leaves. J. Ethnopharmacol. 116, 439–446. doi: 10.1016/j.jep.2007.12.010.[PubMed] [Cross Ref]
• Coppin J. (2008). A Study of the Nutritional and Medicinal Values of Moringa oleifera Leaves from sub-Saharan Africa: Ghana, Rwanda, Senegal and Zambia. M.Sc. thesis, Rutgers University-Graduate School-New Brunswick, New Brunswick.
• Coskun O., Kanter M., Korkmaz A., Oter S. (2005). Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas.Pharmacol. Res. 51, 117–123. doi: 10.1016/j.phrs.2004.06.002. [PubMed] [Cross Ref]
• Dhalla N. S., Temsah R. M., Netticadan T. (2000). Role of oxidative stress in cardiovascular diseases. J. Hypertens. 18, 655–673. doi: 10.1097/00004872-200018060-00002. [PubMed][Cross Ref]
• Dieye A. M., Sarr A., Diop S. N., Ndiaye M., Sy G. Y., Diarra M., Rajraji Gaffary I., Ndiaye Sy A., Faye B. (2008). Medicinal plants and the treatment of diabetes in Senegal: survey with patients.Fundam. Clin. Pharmacol. 22, 211–216. doi: 10.1111/j.1472-8206.2007.00563.x. [PubMed][Cross Ref]
• Dokken B. B. (2008). The pathophysiology of cardiovascular disease and diabetes: beyond blood pressure and lipids. Diabetes Spectr. 21, 160–165. doi: 10.2337/diaspect.21.3.160. [Cross Ref]
• Edwards R. L., Lyon T., Litwin S. E., Rabovsky A., Symons J. D., Jalili T. (2007). Quercetin reduces blood pressure in hypertensive subjects. J. Nutr. 137, 2405–2411. [PubMed]
• Faizi S., Siddiqui B. S., Saleem R., Aftab K., Shaheen F., Gilani A. H. (1998). Hypotensive constituents from the pods of Moringa oleifera. Planta Med. 64, 225–228. doi: 10.1055/s-2006-957414. [PubMed] [Cross Ref]
• Faizi S., Siddiqui B. S., Saleem R., Siddiqui S., Aftab K. (1992). Isolation and structure elucidation of novel hypotensive agents, niazinin A, niazinin B, niazimicin and niaziminin A+B fromMoringa oleifera: the first naturally occurring thiocarbamates. J. Chem. Soc. 1, 3237–3241.
• Faizi S., Siddiqui B. S., Saleem R., Siddiqui S., Aftab K., Gilani A. H. (1994). Isolation and structure elucidation of new nitrile and mustard oil glycosides from Moringa oleifera and their effect on blood pressure. J. Nat. Prod. 57, 1256–1261. doi: 10.1021/np50111a011. [PubMed] [Cross Ref]
• Fakurazi S., Hairuszah I., Nanthini U. (2008). Moringa oleifera Lam prevents acetaminophen induced liver injury through restoration of glutathione level. Food Chem. Toxicol. 46, 2611–2615. doi: 10.1016/j.fct.2008.04.018. [PubMed] [Cross Ref]
• Gerich J. E. (2000). Physiology of glucose homeostasis. Diabetes Obes. Metab. 2, 345–350. doi: 10.1046/j.1463-1326.2000.00085.x. [PubMed] [Cross Ref]
• Ghasi S., Nwobodo E., Ofili J. O. (2000). Hypocholesterolemic effects of crude extract of leaf ofMoringa oleifera Lam in high-fat diet fed Wistar rats. J. Ethnopharmacol. 69, 21–25. doi: 10.1016/S0378-8741(99)00106-3. [PubMed] [Cross Ref]
• Ghiridhari V. V. A., Malhati D., Geetha K. (2011). Anti-diabetic properties of drumstick (Moringa oleifera) leaf tablets. Int. J. Health Nutr. 2, 1–5.
• Ghosh S., Chopra N. R., Dutt A. (1935). Chemical examination of bark of Moringa pterygosperma. Indian J. Med. Res. 22, 789.
• Gowrishankar R., Kumar M., Menon V., Divi S. M., Saravanan M., Magudapathy P., Panigrahi B. K., Nair K. G., Venkataramaniah K. (2010). Trace element studies on Tinospora cordifolia(Menispermaceae), Ocimum sanctum (Lamiaceae), Moringa oleifera (Moringaceae), andPhyllanthus niruri (Euphorbiaceae) using PIXE. Biol. Trace Elem. Res. 133, 357–363. doi: 10.1007/s12011-009-8439-1. [PubMed] [Cross Ref]
• Gupta A., Gautam M. K., Singh R. K., Kumar M. V., Rao Ch V., Goel R. K., Anupurba S. (2010).Immunomodulatory effect of Moringa oleifera Lam. extract on cyclophosphamide induced toxicity in mice. Indian J. Exp. Biol. 48, 1157–1160. [PubMed]
• Havel R. J., Kane J. P. (2001). “Tructure and metabolism of plasma lipoproteins,” in The Metabolic and Molecular Basis of Inherited Disease, eds Scriver C. R., Beaudet A. L., Sly W. S., Valle M. D., Childs B., Kinzler K. W., Vogelstein B., editors. (New York: McGraw-Hill; ), 2705–2716.
• Hemmerle H., Burger H. J., Below P., Schubert G., Rippel R., Schindler P. W., Paulus E., Herling A. W. (1997). Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase. J. Med. Chem. 40, 137–145. doi: 10.1021/jm9607360.[PubMed] [Cross Ref]
• Horton J. D. (2002). Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis. Biochem. Soc. Trans. 30, 1091–1095. doi: 10.1042/BST0301091. [PubMed] [Cross Ref]
• Horton J. D., Cohen J. C., Hobbs H. H. (2009). PCSK9: a convertase that coordinates LDL catabolism. J. Lipid Res. 50(Suppl.), S172–S177. doi: 10.1194/jlr.R800091-JLR200.[PMC free article] [PubMed] [Cross Ref]
• Hossain P., Kawar B., El Nahas M. (2007). Obesity and diabetes in the developing world – a growing challenge. N. Engl. J. Med. 356, 213–215. doi: 10.1056/NEJMp068177. [PubMed][Cross Ref]
• Iffiu-Soltesz Z., Wanecq E., Lomba A., Portillo M. P., Pellati F., Szoko E., Bour S., Woodley J., Milagro F. I., Alfredo Martinez J., Valet P., Carpene C. (2010). Chronic benzylamine administration in the drinking water improves glucose tolerance, reduces body weight gain and circulating cholesterol in high-fat diet-fed mice. Pharmacol. Res. 61, 355–363. doi: 10.1016/j.phrs.2009.12.014. [PubMed] [Cross Ref]
• Iqbal S., Bhanger M. I. (2006). Effect of season and production location on antioxidant activity ofMoringa oleifera leaves grown in Pakistan. J. Food Compost. Anal. 19, 544–551. doi: 10.1016/j.jfca.2005.05.001. [Cross Ref]
• Jain P. J., Patil S. D., Haswani N. G., Girase M. V., Surana S. J. (2010). Hypolipidemic activity ofMoringa oleifera Lam., Moringaceae, on high fat died-induced hyperlipidemia in albino rats. Braz. J. Pharmacogn. 20, 969–973.
• Jaiswal D., Kumar Rai P., Kumar A., Mehta S., Watal G. (2009). Effect of Moringa oleifera Lam. leaves aqueous extract therapy on hyperglycemic rats. J. Ethnopharmacol. 123, 392–396. doi: 10.1016/j.jep.2009.03.036. [PubMed] [Cross Ref]
• Joshi P., Mehta D. (2010). Effect of dehydration on the nutritive value of drumstick leaves.Metabolomics 1, 5–9.
• Juliani H. R., Yudy Fonseca Y., Dan Acquaye A., Halimu Malumo H., Malainy D., Simon J. E. (2009). “Nutritional assessment of Moringa (Moringa spp.) from Ghana, Senegal and Zambia,” inAfrican Natural Plant Products: New Discoveries and Challenges in Chemistry and Quality, eds Juliani H. R., Simon J. E., Ho C. T., editors. (Washington: American Chemical Society; ), 469–484.
• Juzwiak S., Wojcicki J., Mokrzycki K., Marchlewicz M., Bialecka M., Wenda-Rozewicka L., Gawronska-Szklarz B., Drozdzik M. (2005). Effect of quercetin on experimental hyperlipidemia and atherosclerosis in rabbits. Pharmacol. Rep. 57, 604–609. [PubMed]
• Kamada C., da Silva E. L., Ohnishi-Kameyama M., Moon J. H., Terao J. (2005). Attenuation of lipid peroxidation and hyperlipidemia by quercetin glucoside in the aorta of high cholesterol-fed rabbit. Free Radic. Res. 39, 185–194. doi: 10.1080/10715760400019638. [PubMed] [Cross Ref]
• Kaneto H., Katakami N., Kawamori D., Miyatsuka T., Sakamoto K., Matsuoka T. A., Matsuhisa M., Yamasaki Y. (2007). Involvement of oxidative stress in the pathogenesis of diabetes. Antioxid. Redox Signal. 9, 355–366. doi: 10.1089/ars.2006.1465. [PubMed] [Cross Ref]
• Karthikesan K., Pari L., Menon V. P. (2010a). Antihyperlipidemic effect of chlorogenic acid and tetrahydrocurcumin in rats subjected to diabetogenic agents. Chem. Biol. Interact. 188, 643–650. doi: 10.1016/j.cbi.2010.07.026. [PubMed] [Cross Ref]
• Karthikesan K., Pari L., Menon V. P. (2010b). Combined treatment of tetrahydrocurcumin and chlorogenic acid exerts potential antihyperglycemic effect on streptozotocin-nicotinamide-induced diabetic rats. Gen. Physiol. Biophys. 29, 23–30. doi: 10.4149/gpb_2010_01_23. [PubMed][Cross Ref]
• Kasolo J. N., Bimenya G. S., Ojok L., Ochleng J., Ogwal-Okeng J. W. (2010). Phyochemicals and uses of Moringa oleifera leaves in Ugandan rural communities. J. Med. Plant Res. 4, 753–757.
• Kumar P. S., Mishra D., Ghosh G., Panda G. S. (2010). Medicinal uses and pharmacological properties of Moringa oleifera. Int. J. Phytomed. 2, 210–216. doi: 10.5138/ijpm.2010.0975.0185.02017. [Cross Ref]
• Kumari D. J. (2010). Hypoglycemic effect of Moringa oleifera and Azadirachta indica in type-2 diabetes. Bioscan 5, 211–214.
• Lako J., Trenerry V. C., Wahlqvist M., Wattanapenpaiboon N., Sotheeswaran S., Premier R. (2007). Phytochemical flavonols, carotenoids and the antioxidant properties of a wide selection of Fijian fruit, vegetables and other readily available foods. Food Chem. 101, 1727–1741. doi: 10.1016/j.foodchem.2006.01.031. [Cross Ref]
• Libby P., Ridker P. M., Hansson G. K. (2011). Progress and challenges in translating the biology of atherosclerosis. Nature 473, 317–325. doi: 10.1038/nature10146. [PubMed] [Cross Ref]
• Like A. A., Rossini A. A. (1976). Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193, 415–417. doi: 10.1126/science.180605. [PubMed] [Cross Ref]
• Limon-Pacheco J., Gonsebatt M. E. (2009). The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress. Mutat. Res. 674, 137–147. [PubMed]
• Lin X., Racette S. B., Lefevre M., Spearie C. A., Most M., Ma L., Ostlund R. E., Jr. (2010). The effects of phytosterols present in natural food matrices on cholesterol metabolism and LDL-cholesterol: a controlled feeding trial. Eur. J. Clin. Nutr. 64, 1481–1487. doi: 10.1038/ejcn.2010.180. [PubMed] [Cross Ref]
• Mahajan S., Mehta A. (2009). Curative effect of hydroalcoholic extract of leaves of Moringa oleifera lam. against adjuvant induced established arthritis in rats. Niger. J. Nat. Prod. Med. 13, 13–22.
• Mahajan S. G., Mehta A. A. (2010). Immunosuppressive activity of ethanolic extract of seeds ofMoringa oleifera Lam. in experimental immune inflammation. J. Ethnopharmacol. 130, 183–186. doi: 10.1016/j.jep.2010.04.024. [PubMed] [Cross Ref]
• Manguro L. O., Lemmen P. (2007). Phenolics of Moringa oleifera leaves. Nat. Prod. Res. 21, 56–68. doi: 10.1080/14786410601035811. [PubMed] [Cross Ref]
• Manickam P., Rathod A., Panaich S., Hari P., Veeranna V., Badheka A., Jacob S., Afonso L. (2011). Comparative prognostic utility of conventional and novel lipid parameters for cardiovascular disease risk prediction: do novel lipid parameters offer an advantage? J. Clin. Lipidol. 5, 82–90. doi: 10.1016/j.jacl.2010.12.001. [PubMed] [Cross Ref]
• Mehta K., Balaraman R., Amin A. H., Bafna P. A., Gulati O. D. (2003). Effect of fruits of Moringa oleifera on the lipid profile of normal and hypercholesterolaemic rabbits. J. Ethnopharmacol. 86, 191–195. doi: 10.1016/S0378-8741(03)00075-8. [PubMed] [Cross Ref]
• Monera T. G., Maponga C. C. (2010). Moringa oleifera supplementation by patients on antiretroviral therapy. J. Int. AIDS Soc. 13, 188. doi: 10.1186/1758-2652-13-S4-P188. [Cross Ref]
• Muangnoi C., Chingsuwanrote P., Praengamthanachoti P., Svasti S., Tuntipopipat S. (2011).Moringa oleifera pod inhibits inflammatory mediator production by lipopolysaccharide-stimulated RAW 264.7 murine macrophage cell lines. Inflammation. [Epub ahead of print]. doi: 10.1007/s10753-011-9334-4. [Cross Ref]
• Mukunzi D., Nsor-Atindana J., Xiaoming Z., Gahungu A., Karangwa E., Mukamurezi G., Al-Domi H., Princewill-Ogbonna I. L., Ogbonna P. C., Arief N. J. (2011). Comparison of volatile profile of Moringa oleifera leaves from Rwanda and China using HS-SPME. Pakistan J. Nutr. 10, 602–608. doi: 10.3923/pjn.2011.602.608. [Cross Ref]
• Nambiar V. S., Guin P., Parnami S., Daniel M. (2010). Impact of antioxidants from drumstick leaves on the lipid profile of hyperlipidemics. J. Herb. Med. Toxicol. 4, 165–172.
• Ndong M., Uehara M., Katsumata S., Sato S., Suzuki K. (2007a). Preventive effects of Moringa oleifera (Lam) on hyperlipidemia and hepatocyte ultrastructural changes in iron deficient rats.Biosci. Biotechnol. Biochem. 71, 1826–1833. doi: 10.1271/bbb.60644. [PubMed] [Cross Ref]
• Ndong M., Uehara M., Katsumata S., Suzuki K. (2007b). Effects of oral administration of Moringa oleifera Lam on glucose tolerance in Goto-Kakizaki and Wistar rats. J. Clin. Biochem. Nutr. 40, 229–233. doi: 10.3164/jcbn.40.229. [PMC free article] [PubMed] [Cross Ref]
• Olson M. E. (2002). Combining data from DNA sequences and morphology for a phylogeny of Moringaceae (Brassicales). Syst. Bot. 27, 55–73.
• Pari L., Kumar N. A. (2002). Hepatoprotective activity of Moringa oleifera on antitubercular drug-induced liver damage in rats. J. Med. Food 5, 171–177. doi: 10.1089/10966200260398206.[PubMed] [Cross Ref]
• Ramachandran C., Peter K. V., Gopalakrishnan P. K. (1980). Drumstick (Moringa oleifera): a multipurpose Indian vegetable. Econ. Bot. 34, 276–283. doi: 10.1007/BF02858648. [Cross Ref]
• Rana J. S., Nieuwdorp M., Jukema J. W., Kastelein J. J. (2007). Cardiovascular metabolic syndrome – an interplay of, obesity, inflammation, diabetes and coronary heart disease. Diabetes Obes. Metab. 9, 218–232. doi: 10.1111/j.1463-1326.2006.00594.x. [PubMed] [Cross Ref]
• Rice-Evans C. (2001). Flavonoid antioxidants. Curr. Med. Chem. 8, 797–807. [PubMed]
• Rivera L., Moron R., Sanchez M., Zarzuelo A., Galisteo M. (2008). Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity (Silver Spring) 16, 2081–2087. doi: 10.1038/oby.2008.315. [PubMed] [Cross Ref]
• Robertson R. P., Harmon J., Tran P. O., Poitout V. (2004). Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53(Suppl. 1), S119–S124. doi: 10.2337/diabetes.53.3.633. [PubMed] [Cross Ref]
• Rodrigo R., Gonzalez J., Paoletto F. (2011). The role of oxidative stress in the pathophysiology of hypertension. Hypertens. Res. 34, 431–440. doi: 10.1038/hr.2010.264. [PubMed] [Cross Ref]
• Rodriguez de Sotillo D. V., Hadley M. (2002). Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J. Nutr. Biochem. 13, 717–726. doi: 10.1016/S0955-2863(02)00231-0. [PubMed] [Cross Ref]
• Ryter S. W., Kim H. P., Hoetzel A., Park J. W., Nakahira K., Wang X., Choi A. M. (2007).Mechanisms of cell death in oxidative stress. Antioxid. Redox Signal. 9, 49–89. doi: 10.1089/ars.2007.9.49. [PubMed] [Cross Ref]
• Saleem R. (1995). Study of Chemical Constituents of Moringa Oleifera Lam. Ph.D. thesis, University of Karachi, Karachi.
• Sashidhara K. V., Rosaiah J. N., Tyagi E., Shukla R., Raghubir R., Rajendran S. M. (2009). Rare dipeptide and urea derivatives from roots of Moringa oleifera as potential anti-inflammatory and antinociceptive agents. Eur. J. Med. Chem. 44, 432–436. doi: 10.1016/j.ejmech.2008.08.004.[PubMed] [Cross Ref]
• Schneider C., Segre T. (2009). Green tea: potential health benefits. Am. Fam. Physician 79, 591–594. [PubMed]
• Siddhuraju P., Becker K. (2003). Antioxidant properties of various solvent extracts of total phenolic constituents from three different agroclimatic origins of drumstick tree (Moringa oleifera Lam.) leaves. J. Agric. Food Chem. 51, 2144–2155. doi: 10.1021/jf020444+. [PubMed] [Cross Ref]
• Sniderman A., McQueen M., Contois J., Williams K., Furberg C. D. (2010). Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol? J. Clin. Lipidol. 4, 152–155. doi: 10.1016/j.jacl.2010.01.005. [PubMed][Cross Ref]
• Sreelatha S., Padma P. R. (2009). Antioxidant activity and total phenolic content of Moringa oleifera leaves in two stages of maturity. Plant Foods Hum. Nutr. 64, 303–311. doi: 10.1007/s11130-009-0141-0. [PubMed] [Cross Ref]
• Steinberg D. (2002). Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat. Med. 8, 1211–1217. doi: 10.1038/nm1102-1211. [PubMed] [Cross Ref]
• Stumvoll M., Goldstein B. J., van Haeften T. W. (2005). Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365, 1333–1346. doi: 10.1016/S0140-6736(05)61032-X. [PubMed][Cross Ref]
• Sudha P., Asdaq S. M., Dhamingi S. S., Chandrakala G. K. (2010). Immunomodulatory activity of methanolic leaf extract of Moringa oleifera in animals. Indian J. Physiol. Pharmacol. 54, 133–140. [PubMed]
• Sulaiman M. R., Zakaria Z. A., Bujarimin A. S., Somchit M. N., Israf D. A., Moin S. (2008).Evaluation of Moringa oleifera aqueous extract for antinociceptive and anti-inflammatory activities in animal models. Pharmacol. Biol. 46, 838–845. doi: 10.1080/13880200802366710.[Cross Ref]
• Thurber M. D., Fahey J. W. (2009). Adoption of Moringa oleifera to combat under-nutrition viewed through the lens of the “diffusion of innovations” theory. Ecol. Food Nutr. 48, 212–225. doi: 10.1080/03670240902794598. [PMC free article] [PubMed] [Cross Ref]
• Torimiro D. O., Odeyinka S. M., Okorie V. O., Akinsuyi M. A. (2009). Gender analysis of socio-cultural perception of Moringa oeifera amongst farmers in southwestern Nigeria. J. Int. Womens Stud. 10, 188–202.
• Tunnicliffe J. M., Eller L. K., Reimer R. A., Hittel D. S., Shearer J. (2011). Chlorogenic acid differentially affects postprandial glucose and glucose-dependent insulinotropic polypeptide response in rats. Appl. Physiol. Nutr. Metab. 36, 650–659. doi: 10.1139/h11-072. [PubMed][Cross Ref]
• van Dijk A. E., Olthof M. R., Meeuse J. C., Seebus E., Heine R. J., van Dam R. M. (2009). Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance. Diabetes Care 32, 1023–1025. doi: 10.2337/dc09-0207. [PMC free article][PubMed] [Cross Ref]
• Verma A. R., Vijayakumar M., Mathela C. S., Rao C. V. (2009). In vitro and in vivo antioxidant properties of different fractions of Moringa oleifera leaves. Food Chem. Toxicol. 47, 2196–2201. doi: 10.1016/j.fct.2009.06.005. [PubMed] [Cross Ref]
• WHO. (2003). Good Agricultural and Collection Practices (Gacp) for Medicinal Plants. Geneva: World Heath Organization.
• Wild S., Roglic G., Green A., Sicree R., King H. (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047–1053. doi: 10.2337/diacare.27.5.1047. [PubMed] [Cross Ref]
• William F., Lakshminarayanan S., Chegu H. (1993). Effect of some Indian vegetables on the glucose and insulin response in diabetic subjects. Int. J. Food Sci. Nutr. 44, 191–196. doi: 10.3109/09637489309017439. [Cross Ref]
• Yusuf S., Reddy S., Ounpuu S., Anand S. (2001). Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 104, 2855–2864. doi: 10.1161/hc4701.099488. [PubMed][Cross Ref]
• Zhang M., Swarts S. G., Yin L., Liu C., Tian Y., Cao Y., Swarts M., Yang S., Zhang S. B., Zhang K., Ju S., Olek D. J., Jr., Schwartz L., Keng P. C., Howell R., Zhang L., Okunieff P. (2011).Antioxidant properties of quercetin. Adv. Exp. Med. Biol. 915, 283–289. doi: 10.1007/978-1-4419-7756-4_38. [PubMed] [Cross Ref]
• Zhang X., Wang W., Xiao K. (2010). “Novel omics technologies in neutraceutics and functional food research,” in Genomics, Proteomics, and Metabolomics in Nutraceuticals and Functional Foods, eds Bagchi D., Lau F. C., Bagchi M., editors. (Ames, IA: Wiley-Blackwell; ), 11–22.

---

Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

sources from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290775/